From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982

Biosci Rep. 1983 Sep;3(9):791-813. doi: 10.1007/BF01133779.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • 8,11,14-Eicosatrienoic Acid / metabolism
  • Alprostadil
  • Animals
  • Arachidonic Acid
  • Arachidonic Acids / metabolism*
  • Blood Platelets / metabolism
  • Chemical Phenomena
  • Chemistry
  • Humans
  • Leukotriene A4
  • Leukotriene B4 / metabolism*
  • Leukotriene B4 / pharmacology
  • Leukotriene E4
  • Platelet Aggregation
  • Prostaglandin Endoperoxides / isolation & purification
  • Prostaglandin Endoperoxides / metabolism*
  • Prostaglandin Endoperoxides / pharmacology
  • Prostaglandin Endoperoxides, Synthetic / metabolism
  • Prostaglandin H2
  • Prostaglandins / biosynthesis
  • Prostaglandins E / biosynthesis
  • Prostaglandins F / biosynthesis
  • Prostaglandins G / metabolism
  • Prostaglandins H / metabolism
  • SRS-A / analogs & derivatives
  • SRS-A / metabolism*
  • SRS-A / pharmacology
  • Thromboxane A2 / pharmacology
  • Thromboxane B2 / metabolism
  • Thromboxanes / metabolism*

Substances

  • Arachidonic Acids
  • Leukotriene A4
  • Prostaglandin Endoperoxides
  • Prostaglandin Endoperoxides, Synthetic
  • Prostaglandins
  • Prostaglandins E
  • Prostaglandins F
  • Prostaglandins G
  • Prostaglandins H
  • SRS-A
  • Thromboxanes
  • Leukotriene B4
  • Arachidonic Acid
  • Prostaglandin H2
  • prostaglandin G2
  • Thromboxane B2
  • Thromboxane A2
  • Leukotriene E4
  • Alprostadil
  • 8,11,14-Eicosatrienoic Acid
  • prostaglandin F1